Guggenheim raises Genmab price target to $58
Guggenheim lifted its Genmab price target to $58.00 per share from $54.00, according to Benzinga.
Story updates
01:17:59 PM UTC
SquawkNews
Genmab Price Target Raised to $58.00/Share From $54.00 by Guggenheim